Drug ID: | NPD5274 |
Drug Name: | |
Molecular Formula: | C22H30N6OS |
Canonical SMILES: | O=C(N1CSCC1)[C@H]1NC[C@H](C1)N1CCN(CC1)c1cc(nn1c1ccccc1)C |
Standard InCHI: | InChI=1S/C22H30N6OS/c1-17-13-21(28(24-17)18-5-3-2-4-6-18)26-9-7-25(8-10-26)19-14-20(23-15-19)22(29)27-11-12-30-16-27/h2-6,13,19-20,23H,7-12,14-16H2,1H3/t19-,20-/m0/s1 |
Standard InCHIKey: | WGRQANOPCQRCME-PMACEKPBSA-N |
Max Developmental Stage: | Clinical (unspecified phase) |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DNCL002927 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | 11949652 |
ChEBI | |
CAS Number |
Molecular Weight | 426.22 |
ALogP | -0.3943 |
MLogP | 3 |
XLogP | 2.598 |
HDA | 7 |
HBD | 1 |
Rotatable Bonds | 6 |
TPSA | 81.42 |
RO5 Violation | 0 |